However, some studies proposed a thoroughly opposite view, concluding that the downregulation of HOXB9 was correlated with the poor survival prognosis of patients bearing adenocarcinoma of the colon, ductal adenocarcinoma of the pancreas, and gastric carcinoma (30–32). This evidence concerns the gene HOXB9 and gastric carcinoma.